| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.9 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.009 | 0.9 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |